Enveric Biosciences, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q1 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Enveric Biosciences, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q1 2025.
  • Enveric Biosciences, Inc. Entity Common Stock, Shares Outstanding for the quarter ending March 27, 2025 was 2.47M shares, a 66.1% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2025 2.47M -4.82M -66.1% Mar 27, 2025 10-K 2025-03-28
Q3 2024 9.94M +7.62M +328% Nov 12, 2024 10-Q 2024-11-14
Q2 2024 8.92M +6.77M +315% Aug 9, 2024 10-Q 2024-08-12
Q1 2024 7.29M +5.22M +251% Mar 21, 2024 10-K 2024-03-26
Q3 2023 2.32M +243K +11.7% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 2.15M +573K +36.4% Aug 9, 2023 10-Q 2023-08-11
Q1 2023 2.08M -50.5M -96% Mar 30, 2023 10-K/A 2023-06-09
Q3 2022 2.08M -29.3M -93.4% Nov 11, 2022 10-Q 2022-11-14
Q2 2022 1.57M -19.9M -92.7% Aug 11, 2022 10-Q 2022-08-12
Q1 2022 52.6M +33.1M +170% Mar 30, 2022 10-K 2022-03-31
Q3 2021 31.4M +23.9M +319% Nov 9, 2021 10-Q 2021-11-15
Q2 2021 21.4M +15.7M +274% Aug 13, 2021 10-Q 2021-08-13
Q1 2021 19.5M +16.2M +499% Mar 29, 2021 10-K 2021-04-01
Q3 2020 7.49M -55.3M -88.1% Nov 13, 2020 10-Q 2020-11-16
Q2 2020 5.74M -46.7M -89.1% Aug 11, 2020 10-K/A 2020-08-12
Q1 2020 3.25M -43.8M -93.1% Mar 22, 2020 10-K 2020-03-25
Q3 2019 62.8M +23.2M +58.6% Nov 6, 2019 10-Q 2019-11-08
Q2 2019 52.4M +29.5M +129% Aug 9, 2019 10-Q 2019-08-14
Q1 2019 47M +28.2M +150% Mar 22, 2019 10-K 2019-03-26
Q3 2018 39.6M +23.8M +150% Nov 8, 2018 10-Q 2018-11-14
Q2 2018 22.9M +8.22M +56.1% Aug 8, 2018 10-Q 2018-08-14
Q1 2018 18.8M +4.21M +28.9% Mar 29, 2018 10-K 2018-04-02
Q3 2017 15.9M +1.97M +14.2% Oct 30, 2017 10-Q 2017-11-13
Q2 2017 14.7M +1.16M +8.64% Aug 10, 2017 10-Q 2017-08-14
Q1 2017 14.6M +2.71M +22.8% Mar 20, 2017 10-K/A 2017-04-04
Q3 2016 13.9M Nov 14, 2016 10-Q 2016-11-14
Q2 2016 13.5M Aug 12, 2016 10-Q 2016-08-12
Q1 2016 11.9M -3.54M -22.9% Mar 15, 2016 10-KT 2016-03-15
Q4 2015 11.6M Nov 16, 2015 10-Q 2015-11-23
Q1 2015 15.4M 0 0% Mar 20, 2015 10-K 2015-03-31
Q3 2014 15.4M +3.27M +26.9% Nov 10, 2014 10-Q 2015-08-18
Q2 2014 15.4M +3.27M +26.9% Jul 20, 2014 10-Q 2014-11-13
Q1 2014 15.4M +3.27M +26.9% May 1, 2014 10-Q/A 2014-05-08
Q3 2013 12.1M 0 0% Sep 30, 2013 10-Q 2013-11-06
Q2 2013 12.1M 0 0% Jul 31, 2013 10-Q 2013-08-01
Q1 2013 12.1M 0 0% Feb 28, 2013 10-K 2013-02-28
Q3 2012 12.1M 0 0% Nov 9, 2012 10-Q 2012-11-13
Q2 2012 12.1M -52.9M -81.3% Jul 31, 2012 10-Q 2012-08-01
Q1 2012 12.1M Mar 3, 2012 10-K 2012-03-07
Q3 2011 12.1M Oct 31, 2011 10-Q 2011-11-14
Q2 2011 65M Aug 1, 2011 10-Q 2011-08-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.